Noninferiority trials in clinical practice

Monika Marko; Rafał Pawliczak

doi:10.5114/pja.2019.91219

eISSN: 2391-6052
ISSN: 2353-3854

Alergologia Polska - Polish Journal of Allergology

Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

4/2019
vol. 6

Send email

Copy url:

abstract:

Review paper

Noninferiority trials in clinical practice

Monika Marko

¹

,

Rafał Pawliczak

¹

Zakład Immunopatologii, Wydział Lekarski, Oddział Nauk Biomedycznych, Uniwersytet Medyczny w Łodzi

Alergologia Polska – Polish Journal of Allergology 2019; 6, 4: 152–159

DOI: https://doi.org/10.5114/pja.2019.91219

Online publish date: 2019/12/22

View full text Get citation

PlumX metrics:

With the development of new therapeutic strategies, it is becoming increasingly difficult to develop drugs that show better efficacy. That is why new treatments are being sought that have similar efficacy, but in other respects show better quality. This trend stimulates the development of clinical trials aimed at demonstrating that experimental treatment is not (much) worse than control treatment. Such studies are called noninferiority trials, which we describe in this paper in relation to superiority trials and equivalence trials. We also pay attention to the problems you may encounter when conducting noninferiority trials.

keywords:

Noninferiority trials in clinical practice

Monika Marko 1 , Rafał Pawliczak 1

noninferiority trials, clinical practice, drugs’ efficacy

Monika Marko

¹

,

Rafał Pawliczak

¹